Evidence map›Paper›PMID 38881881›Full record

SynthesisFrontiers in pharmacology2024

Anti-inflammatory and/or immunomodulatory activities of

Gustavo Marin Arado, Pedro de Padua G Amatto, Mozart Marins, Elen Sanchez Rizzi, Suzelei de Castro França, Juliana da Silva Coppede, Fábio Carmona, Ana Maria Soares Pereira

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Evaluation of ImoviralFrontiers in immunology · 2026
    Article
  2. International journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gustavo Marin AradoDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Pedro de Padua G AmattoDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Mozart MarinsDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Elen Sanchez RizziDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Suzelei de Castro FrançaDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Juliana da Silva CoppedeDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.
Fábio CarmonaDepartment of Pediatrics, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Ana Maria Soares PereiraDepartment of Biotechnology, University of Ribeirão Preto, Sao Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We conducted a systematic review and meta-analysis of preclinical studies published before 26 July 2023, identified in PubMed, Embase, and Scopus. Four independent reviewers extracted the data and assessed the risks of bias. The effects of Results: Twenty-four of 523 studies were included. Conclusion: Many extracts of stem bark, roots, and leaves of

Indexed as

inflammationinflammatory diseasesinflammatory mediatorsmedicinal plantRubiaceae

Identifiers

PMID38881881
PMCPMC11176511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.